Exportation of unethical practices to low and middle income countries in biomedical research
Substandard ethical practices in biomedical research have been exported from more developed countries to less developed countries worldwide. The term for this practice is called ethics dumping, which can be described as exporting, in clinical research, sensitive ethical practices from more developed...
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2017 |
| País: | México |
| Institución: | Universidad Nacional Autónoma de México |
| Repositorio: | Redalyc-UNAM |
| OAI Identifier: | oai:redalyc.org:78351101013 |
| Acceso en línea: | https://www.redalyc.org/articulo.oa?id=78351101013 https://www.redalyc.org/journal/783/78351101013/ https://www.redalyc.org/journal/783/78351101013/html/ https://www.redalyc.org/journal/783/78351101013/78351101013.epub https://www.redalyc.org/journal/783/78351101013/movil |
| Access Level: | acceso abierto |
| Palabra clave: | Derecho ethics ethics dumping research ethics Clinical research research bioethics |
| Sumario: | Substandard ethical practices in biomedical research have been exported from more developed countries to less developed countries worldwide. The term for this practice is called ethics dumping, which can be described as exporting, in clinical research, sensitive ethical practices from more developed to less developed countries, with subpar requirements and other economic or operational advantages that would be inadmissible in developed countries. Examples for this practice are described, as well as its origin, receptivity, and perpetuation, together with some preliminary guidance and advice in order to work towards possible solutions for this ethically sensitive issue in the future. |
|---|